HBV Disease Progression
ILCA 2013: High HBV Viral Load Raises Risk of Progression to Liver Cancer
- Details
- Category: Liver Cancer/HCC
- Published on Friday, 04 October 2013 00:00
- Written by Liz Highleyman
Hepatitis B patients with high HBV DNA levels, indicating active viral replication, are more likely to experience progression of abnormal liver nodules to hepatocellular carcinoma, researchers reported at the 7th International Liver Cancer Association Annual Conference (ILCA 2013) last month in Washington, DC.
ICAAC 2013: Liver Cancer Often Diagnosed Late with Poor Survival in People with HIV
- Details
- Category: Liver Cancer/HCC
- Published on Tuesday, 01 October 2013 00:00
- Written by Liz Highleyman
Hepatocellular carcinoma (HCC) is frequently diagnosed at an advanced stage in HIV positive people with hepatitis B or C coinfection, contributing to a high mortality rate that has changed little in recent years, according to a report at the recent 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2013) in Denver.
Human Stem Cells Used to Create Functional Liver Cells in Mice
- Details
- Category: Liver Transplant - HBV
- Published on Wednesday, 07 August 2013 00:00
- Written by Liz Highleyman
Researchers have discovered a way to generate functional hepatocytes (liver cells) from human stem cells, which worked as expected and increased survival when transplanted into mice with acute liver injury, researchers reported in the July 9, 2013, advance online edition of Stem Cells and Development.
FDA Warns of Hepatitis B Reactivation Risk with Immune-suppressing Cancer Drugs
- Details
- Category: Hepatitis B
- Published on Friday, 27 September 2013 00:00
- Written by FDA
The U.S. Food and Drug Administration (FDA) announced this week that it has approved labeling changes for 2 monoclonal antibody cancer drugs, ofatumumab (Arzerra) and rituximab (Rituxan), adding a stronger "black box" warning that they may cause hepatitis B virus (HBV) reactivation.
DDW 2013: Does HBV Suppression Prevent Liver Disease Progression?
- Details
- Category: HBV Treatment
- Published on Wednesday, 19 June 2013 00:00
- Written by Liz Highleyman
Chronic hepatitis B patients with cirrhosis may still experience liver disease progression even if they undergo antiviral treatment and achieve good virological response, according to a poster presented at the Digestive Disease Week meeting (DDW 2013) last month in Orlando.
Web Design and Development by